Surveys

We invite you to participate in our EANM consensus survey on optical imaging in clinical nuclear medicine designed by the EANM Translational Molecular Imaging & Therapy committee. 

Your input will help identify key indications where optical imaging can enhance nuclear medicine, explore growth opportunities for the field, and define its optimal place within nuclear medicine strategies.

⏰ Please participate before November 15, and share it with colleagues! It will take you only 10–20 minutes to complete.

Participate now

AI is rapidly transforming healthcare and nuclear medicine. To better understand its potential, challenges, and future directions, take part in our anonymous survey designed by the EANM AI Committee and the European Commission’s Joint Research Centre (JRC).

We need insights from everyone: professionals already working with AI, colleagues with little or no experience, and anyone curious about its role in our field. Your input will help build a clearer picture of how AI is perceived, where it is making an impact, and what is needed for responsible integration in healthcare.

⏰ Please participate before November 15, and share it with colleagues! It will take you only 10–20 minutes to complete.

Participate now

As part of the international collaborative initiative gathering the ANZSNM Theranostics Special Interest Group (ANZSNM-TSIG), the International Atomic Energy Agency (IAEA), the SNMMI Technologist Section (SNMMI-TS) and the EANM Technologists Committee (EANM-TC), we invite  all Nuclear Medicine Technologists to participate in the Role of Nuclear Medicine Technologist in Theranostics / Clinical Trials Survey.

The goal of this survey is to investigate, evaluate, and establish recommendations for Nuclear Medicine Technologist (NMT) education, training, and professional competency standards in the field of Theranostics. Your input will directly contribute to the development of evidence-based consensus recommendations, best practice articles, and future guidelines that will harmonise global standards while recognising country-specific practices.

⏰ Please participate before December 15, and share it with colleagues! It will take you only 10 minutes to complete.

Participate now

The EANM Policy Project Group on ACT EU and Clinical Trials invites professionals with experience in clinical research to participate in a short survey (15 questions).

This initiative supports the Accelerating Clinical Trials in the EU (ACT EU) programme, led by the European Commission, EMA and HMA, which aims to modernise and streamline clinical research across Europe.

The survey seeks to identify key challenges, gaps and opportunities for academic and non-commercial sponsors in nuclear medicine, helping to shape EANM’s positioning and contributions to ACT EU and the Reducing Bureaucracy in Clinical Trials Coalition.

⏰ Please participate before December 31, and share it with colleagues! It will take you only 10 minutes to complete.

Participate now

We invite you to participate in the survey on the use, accessibility, and perceived utility of nuclear imaging techniques in intensive care unit (ICU) patients with infectious diseases across European centres.

The survey, also supported by the European Society of Intensive Care Medicine (ESICM), aims to assess how frequently modalities such as 18F-FDG-PET/CT are used, identify the main indications for their application, and highlight the challenges associated with their use in critically ill patients.

It targets ICU physicians, infectious disease specialists, and nuclear medicine experts involved in the care of patients with suspected or confirmed infections.

⏰ It includes up to 35 questions and takes about 10 minutes to complete.

Participate now